Awarded Grants

Shaomeng Wang, Ph.D.: $2,100,885 from NCI for “T Orally active CBP/p300 degraders.” [Developmental Therapeutics]

Weiping Zou, M.D., Ph.D.: $2,009,538 from NCI for “MS4A7 in tumor resistance to immunotherapy.” [Cancer Hematopoiesis and Immunology]

Lesly Dossett, M.D., M.P.H.: $1,433,524 from NCI for “Evaluation of the Implementation and Effectiveness of the American College of Surgeons Operative Standards Program.” [Cancer Control and Population Sciences]

Lara Coughlin, Ph.D.: $1,162,791 from Molina Healthcare for “Improving quality of smoking cessation care among special populations.” [Cancer Control and Population Sciences]

Elena Stoffel, M.D.: $731,901 from Wayne State University (Subaward) for “Genetic Variation in Cancer Risk and Outcomes in African Americans.” [Cancer Control and Population Sciences]

Yatrik Shah, Ph.D.: $591,494 from Ono Pharmaceutical Company for “Induction of ferroptosis through ALKBH8 inhibition.” [Signaling and Tumor Microenvironment]

Marina Pasca Di Magliano, Ph.D.: $184,220 from NCI for “The role of mesothelial-derived cancer-associated fibroblasts in the pathogenesis of pancreatic ductal adenocarcinoma.” [Signaling and Tumor Microenvironment]

Allison Bischoff, B.S.: $184,220 from NCI for “The role of mesothelial-derived cancer-associated fibroblasts in the pathogenesis of pancreatic ductal adenocarcinoma.” [Trainee]

Arul Chinnaiyan, M.D., Ph.D.: $4,166,667 from J.C. Kennedy Foundation, Inc. for “Trailsend Clinical Development of a SWI/SNF Degrader for the Treatment of Advanced Cancer.” [Cancer Genetics]

Imad Shureiqi, M.D.: $2,266,253 from NCI for “PPARD hyperactivation promotes pancreatic intraepithelial neoplasia progression into pancreatic ductal adenocarcinoma.” [Signaling and Tumor Microenvironment]

Vahakn Shahinian, M.D.: $1,937,987 from NCI for “Urology practice consolidation and care for men with prostate cancer.” [Cancer Control and Population Sciences]

Nobuhiko Kamada, Ph.D.: $1,861,609 from NCI for “The oral-gut axis in colorectal cancer.” [Signaling and Tumor Microenvironment]

Tomasz Cierpicki, Ph.D.: $1,854,955 from NCI for “Development of chemical probe targeting NSD3 SET domain in breast cancer.” [Developmental Therapeutics]

Mats Ljungman, Ph.D.: $1,854,706 from NCI for “Precision targeting of bladder cancer using CRISPR.” [Cancer Genetics]

Duxin Sun, Ph.D.: $1,695,760 from NCI for “Therapeutic Cancer NanoVaccine Promotes B/CD 4 T Cell Crosstalk for Durable Anticancer Efficacy.” [Developmental Therapeutics]

Joshi Alumkal, M.D.: $1,695,517 from NCI for “Developing New Treatment Strategies for Neuroendocrine Prostate Cancer.” [Translational and Clinical Research]

Wajd Al-Holou, M.D.: $1,080,000 from NIH for “Defining Tumor Microenvironmental Interactions that drive THY1-Mediated Treatment Resistance in Glioblastoma.” [Translational and Clinical Research]

Maria Castro, Ph.D. (Mentor): $1,080,000 from NIH for “Defining Tumor Microenvironmental Interactions that drive THY1-Mediated Treatment Resistance in Glioblastoma.” [Cancer Hematopoiesis and Immunology]

Pedro Lowenstein, M.D., Ph.D. (Mentor): $1,080,000 from NIH for “Defining Tumor Microenvironmental Interactions that drive THY1-Mediated Treatment Resistance in Glioblastoma.” [Cancer Hematopoiesis and Immunology]

Guizhi Zhu, Ph.D.: $679,599 from Department of Defense for “Circular mRNA Vaccine Platform for Immunotherapy of Breast Cancer Dormancy.” [Developmental Therapeutics]

David Fox, M.D.: $257,125 from NIH for “Immunotherapy of prostate cancer using an anti-CD6 monoclonal antibody.” [Cancer Hematopoiesis and Immunology]

Carl Koschmann, M.D.: $177,969 from Team Lafontaine Ucancervive Foundation for “Targeting mitochondrially driven tumor migration in pediatric diffuse midline glioma.” [Translational and Clinical Research]

John Prensner, M.D., Ph.D.: $135,000 from 2024 Curing Kids Cancer Research Award for “Direct ribosome inhibition for the treatment of atypical teratoid/rhabdoid tumor.” [Cancer Genetics]

Steven Katz, M.D.:$75,000 Discovery Award for “The My Family Genetics (MyFam) Study.” [Cancer Control and Population Sciences]

John Prensner M.D., Ph.D.:$75,000 Discovery Award for “Uncovering oncogenic contexts for microprotein function in childhood brain cancer.” [Cancer Genetics]

Susan Pitt, M.D.: $75,000 Discovery Award for “A Novel Multi-Level Surgeon Behavior Change Intervention to Prevent Overuse of Total Thyroidectomy” [Cancer Control and Population Sciences]